OR35 New Players in the Regulation of Bone Mass

Program: Abstracts - Orals, Poster Previews, and Posters
Oral Session
Bone, Calciotropic Hormones & Vitamin D-Basic/Clinical
Monday, April 4, 2016: 10:00 AM-11:30 AM
Room 205 (BCEC)
Chair:
Erik Imel, MD, Indiana University School of Medicine, Indianapolis,

Disclosures:
EI: Investigator, Ultragenyx Pharmaceutical Inc., Investigator, Merck & Co.. Disclosure Not Provided: PRE
10:00 AM
Marc Nathan Wein, MD/PhD1, Yanke Liang, PhD2, Olga Goransson, PhD3, Elizabeth A Williams4, Nicolas Govea4, Paola Pajevic Divieti, MD/PhD5, Nathanael Gray, PhD2 and Henry M Kronenberg, MD6, (1)Endocrine Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA
(2)Dana Farber Cancer Institute
(3)Lund University
(4)Massachusetts General Hospital, Endocrine Unit
(5)Boston University, MA
(6)Massachusetts General Hospital, Boston, MA
10:15 AM
Qing He, Ph.D.1, Cumhur Aydin2, Marc Nathan Wein, MD/PhD1, Jordan M Spatz1, Regina Goetz3, Moosa Mohammadi3, Antonius Plagge4, Paola Divieti Pajevic5 and Murat Bastepe1, (1)Endocrine Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA
(2)Department of Endodontics, G├╝lhane Military Medical Academy
(3)Department of Biochemistry & Molecular Pharmacology, New York University School of Medicine, New York, NY
(4)Department of Cellular and Molecular Physiology, Institute of Translational Medicine University of Liverpool, Liverpool
(5)Boston University School of Dental Medicine
10:45 AM
Anyonya R Guntur1, Phuong T Le, MS2 and Clifford J Rosen, MD2, (1)Maine Medical Center Research institute, Maine Medical Center, Scarborough, ME
(2)Maine Medical Center Research Institute, Maine Medical Center, Scarborough, ME
11:00 AM
Lina E Aguirre, MD1, Georgia Colleluori2, Richard I Dorin, MD3, David N Robbins, MD4, Clifford R. Qualls, PhD5, Dennis Tan Villareal, MD6 and Reina Condevillamar Villareal, MD6, (1)Department of Endocrinology, Diabetes & Metabolism, New Mexico VA Health Care System, Albuquerque, NM
(2)Endocrinology, Diabetes and Metabolism, Baylor College of Medicine
(3)Department of Endocrinology, Diabetes & Metabolism, University of New Mexico School of Medicine, Albuquerque, NM
(4)Surgery/Urology, New Mexico VA Medical Center, Albuquerque, NM
(5)Clinical & Translational Science Center (Biostatistics), University of New Mexico Health Sciences Center, Albuquerque, NM
(6)Internal Medicine/Endocrinology, Michael E. DeBakey VA Medical Center, Houston, TX
11:15 AM
Sian E Piret, DPhil1, Caroline M Gorvin2, Alistair T Pagnamenta3, Sarah A Howles, DPhil1, Treena Cranston4, Nigel Rust5, M Andrew Nesbit1, Fadil M Hannan, PhD1, Benjamin Glaser6, Jenny C Taylor3, Andreas Emanuel Buchs7 and Rajesh V Thakker, FRS, FMedSci, FRCPath, FRCPE, FRCP1, (1)Oxford Centre for Diabetes, Endocrinology and Metabolism, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom
(2)Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, United Kingdom
(3)Wellcome Trust Centre for Human Genetics, Oxford, United Kingdom
(4)Oxford Molecular Genetics Laboratory, Churchill Hospital, Oxford
(5)The Sir William Dunn School of Pathology, University of Oxford, Oxford, United Kingdom
(6)Hadassah-Hebrew University Medical Center, Jerusalem, Israel
(7)Assaf Harofe Medical Center, Beer Yaacov, Israel

 

The Endocrine Society would like to thank the following organizations for their support: AbbVie Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Chiasma, Inc.; Corcept Therapeutics Incorporated; Eisai, Inc.; Ethicon Endo-Surgery, Inc.; Genzyme, a Sanofi company, Ipsen Biopharmaceuticals, Inc.; Leona M. and Harry B. Helmsley Charitable Trust; Lilly USA, LLC; Medtronic Diabetes; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Pfizer, Inc.; Shire